logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Eikon raised $350.7M in a Series D funding round led by existing investors to advance its cancer trials.

Feb 28, 202510 months ago

Amount Raised

$351 Million

Round Type

series d

LondonFinancial Services

Description

Eikon has successfully raised $350.7 million in a Series D funding round, which will be used to accelerate the development of its cancer therapies. The company has raised over $1.1 billion since its inception in 2019 and plans to expand its clinical studies globally.

Company Information

Company

LSEG

Location

London, England, United Kingdom

About

LSEG (London Stock Exchange Group) is a diversified international markets infrastructure business —earning our clients’ trust for over 300 years. That legacy of customer-focused excellence ensures that you can rely on our expertise in capital formation, intellectual property and risk and balance sheet management. As global leaders in financial indexing, benchmarking and analytic services, we offer unrivalled access to international capital markets. Our high-performance technology solutions enable companies worldwide to access funds for growth and development. And with our Data & Analytics, Capital Markets and Post Trade divisions, we provide a comprehensive, integrated suite of trusted financial market infrastructure services that help our customers pursue—and achieve—their ambitions. You can count on our open access model for unparalleled partnership, flexibility, stability, and support across all of our businesses. That’s how we make a difference— ensuring people can meet their potential—worldwide.

Related People

4 contacts

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech